MedReleaf Gets Approval for Sale of Cannabis Oil Soft Gel Capsules

Cannabis Investing News

MedReleaf announced it received approval for the sale of cannabis oil soft gel capsules by Health Canada.

MedReleaf (TSX:LEAF) announced it received approval for the sale of cannabis oil soft gel capsules by Health Canada.

As quoted in the press release:

“Orally ingested softgel capsules give prescribing physicians and patients precise dosing in a familiar and convenient medicinal form factor. These products provide access to cannabis for an under-served patient community more comfortable taking their medication in a traditional capsule rather than by oil or through vapourizers,” said Robert Gora, Senior Director of Physician Outreach. “As part of MedReleaf’s ongoing focus on patient safety, our softgel capsules are uniquely colour-coded to allow patients to easily differentiate between the specific cultivar or type of oil product that they are consuming, letting patients more safely manage their medication.”

“Our product development teams continue to set the standard for innovation and quality in our industry with pharmaceutical-grade softgel capsules that faithfully capture both cannabinoid and terpenes profiles of our award-winning varieties. The addition of softgel capsules to our product line will enhance our efforts to build physician support for medical cannabis and are more cost effective to produce, easier to swallow, and have a longer shelf-life than standard oil capsules,” added Neil Closner, CEO of MedReleaf.

Click here to read the full press release.

Source: marijuanaindex.com

The Conversation (0)
×